Our Team

Slider
Jason Chew Image

Jason Chew

Research Analyst

Jason Chew is a graduate of the University of California at Berkeley with over 10 years of experience as a scientist at leading biotech companies. He is a published author in a peer-reviewed scientific journal and has has blogged on a variety of industry topics and covered the industry as a freelance journalist. Jason was most recently contributing editor at the biotechnology newsletter CurrinResearch.com.

David

David Sobek

Research Analyst

David Sobek has been writing on biotech for more than 3 years through various outlets with a general focus on small cap oncology and antibiotics companies.

He received his PhD in political science from Pennsylvania State University in 2003 and a BA in international relations from The College of William and Mary in 1997. He has been a contributor to Seeking Alpha and currently writes a weekly biotech column for TheStreet.Com.

Joe-Gantoss

Joe Gantoss

Trading Analyst

Joe Gantos's strategy is well known for it’s emphasis on technical analysis, with particular focus on Japanese Candlestick techniques. Mr. Gantoss uses fundamental analysis and thorough due diligence, to determine the best entry and exit points around clinical and regulatory catalysts.

Overview

The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the FDA. Their published work includes freelance and editorial contributions both print and on-line, clinical and medical research, books and tutorials, as well as contributions to on-line social media. The group's analysis process is based in the member's diversity. We employ a multidisciplinary approach, with peer-review of every report to ensure that our subscribers are receiving cutting edge analysis.

Our Goal

Our goal is to give each subscriber, retail or institutional, the most valuable insights and strategies in the biopharmaceutical sector. We strive to provide our subscribers with actionable market intelligence by leveraging the experience, accomplishments and intellectual horsepower of our founding members.

Our Team, Your Consultants

Our Clients

  • Hedge Funds
  • Venture Capitalists
  • Pharmaceutical Executives
  • Physicians
  • Consultants
  • Scientists
  • Retail Investors

Our work

We provide unparalleled intelligence in the biotech sector, our approach is simple, it is multi-disciplinary and peer-reviewed, so that our clients receive content they can capitalize on.

Are You Ready To Join?

Join

Recent Press

Slider

Log In

JoinLost Password?